By expenditures
| Name | Title | Type |
|---|---|---|
| Daisy Halvorson | Vice President for Finance and Business Affairs | Auditee |
| John Hash | Partner | Auditee |
| Brenda Scherer | Prinicipal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 345325 | 2024 | 2025-03-10 | Brown Edwards | $16.77M |
| 325635 | 2023 | 2024-10-23 | Cliftonlarsonallen LLP | $8.10M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 345325 | 2024 | 2025-03-10 | 1102834 | 2024-002 | Significant Deficiency | Yes | N |
| 345325 | 2024 | 2025-03-10 | 526392 | 2024-002 | Significant Deficiency | Yes | N |
| 325635 | 2023 | 2024-10-23 | 1079976 | 2023-006 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 1079975 | 2023-006 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 1079974 | 2023-006 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 1079973 | 2023-006 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 1079972 | 2023-005 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079971 | 2023-005 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079970 | 2023-005 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079969 | 2023-005 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079968 | 2023-004 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079967 | 2023-004 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079966 | 2023-004 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079965 | 2023-004 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079964 | 2023-003 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079963 | 2023-003 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079962 | 2023-003 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079961 | 2023-003 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 1079960 | 2023-002 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 1079959 | 2023-002 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 1079958 | 2023-002 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 1079957 | 2023-002 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 503534 | 2023-006 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 503533 | 2023-006 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 503532 | 2023-006 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 503531 | 2023-006 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 503530 | 2023-005 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503529 | 2023-005 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503528 | 2023-005 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503527 | 2023-005 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503526 | 2023-004 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503525 | 2023-004 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503524 | 2023-004 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503523 | 2023-004 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503522 | 2023-003 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503521 | 2023-003 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503520 | 2023-003 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503519 | 2023-003 | Significant Deficiency | - | N |
| 325635 | 2023 | 2024-10-23 | 503518 | 2023-002 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 503517 | 2023-002 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 503516 | 2023-002 | Material Weakness | - | N |
| 325635 | 2023 | 2024-10-23 | 503515 | 2023-002 | Material Weakness | - | N |